InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-22.7%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by WEISS MICHAEL S, Chief Executive Officer. Insider active across 4 companies, notably Checkpoint Therapeutics, Inc.. In total, 27 reports have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €2.1m. History available since 10 June 2021. The latest transaction was disclosed on 29 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations27 total
750,000 shares0Common StockSEC:0001437749-25-002292:0
454,153 shares0common stock, par value $0.001SEC:0001415889-25-000402:0
12,638 shares0COMMON STOCKSEC:0001104659-24-129528:0
32,051 shares0COMMON STOCKSEC:0001104659-24-062667:0
1,001,908 shares0Common StockSEC:0001437749-24-000899:0
216,465 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-000900:0
147,058 shares@ US$1.7020.1% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-23-119186:0
Ideal exit: 10 Aug 2024 (T+270)
100,000 shares@ US$10.13100.0% of flowCOMMON STOCKSEC:0001104659-23-091054:0
Ideal exit: 7 May 2024 (T+270)
7,246 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-079112:0
17,483 shares0COMMON STOCKSEC:0001104659-23-071761:0
71,664 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-040923:0
985,000 shares0COMMON STOCKSEC:0001104659-23-032337:0
1,197,604 shares@ US$0.83579.9% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-23-021628:0
Ideal exit: 7 Nov 2023 (T+270)
1,219,294 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-23-001101:0
47,619 shares0COMMON STOCKSEC:0001104659-22-074464:0
1,102,986 shares0Common StockSEC:0001104659-22-053619:0
3,000 shares0COMMON STOCKSEC:0001104659-22-002355:0
3,000 shares0COMMON STOCKSEC:0001104659-22-002355
13,774 shares0COMMON STOCKSEC:0001104659-21-090246
13,774 shares0COMMON STOCKSEC:0001104659-21-090246:0
1,080,770 shares0COMMON STOCKSEC:0001104659-21-084261
1,080,770 shares0COMMON STOCKSEC:0001104659-21-084261:0
16,502 shares0COMMON STOCKSEC:0001104659-21-080364
16,502 shares0COMMON STOCKSEC:0001104659-21-080364:0
510,434 sharesCommon Stock, par value $0.001SEC:0001144204-16-074142:0
25 of 27 declarations
About WEISS MICHAEL S
Michael S. Weiss is the CEO and President at Checkpoint Therapeutics, Inc., TG THERAPEUTICS, INC., and MUSTANG BIO, INC. He has extensive experience in business management and strategic development. Michael is responsible for the overall direction of the companies and the execution of their business strategy.
